ICG plc22 January 2025Q3 update for the nine months ended 31 December 2024
$22bn raised in the last twelve months
Highlights Strong fundraising of $7.2bn in the quarter resulting in $22bn raised in the last twelve months, more than twice as much as raised in calendar 2023 and supporting long-term growth in client capital and management fees
Client commitments included $1.8bn to Strategic Equity and $1.8bn to Europe IX. Europe IX expected to be activated and fee-earning by March 2025
AUM of $107bn (+5.1% q-o-q1); fee-earning AUM of $71bn (+2.8% q-o-q1); AUM not yet earning fees of $20bn
Investment environment remains in line with recent quarters
Balance sheet investment portfolio during the quarter generated positive NIR in all asset classes and net cash realisations
AAA ESG rating awarded by MSCI for the fourth...
Kitron: Kongsberg Awards Kitron New Order for Naval Strike Missile Electronics
Written by Customer Service on . Posted in Public Companies.
(2025-01-22) Kitron has received an order with a value of NOK 300 million from Kongsberg Defence & Aerospace (KONGSBERG).
The order covers electronics for the Naval Strike Missile (NSM) and extends a similar contract awarded in June 2024.
Deliveries under the new order are set to commence in 2026, with production taking place at Kitron’s facilities in Arendal, Norway.
“We are very pleased to announce this order, which confirms Kitron’s position as a robust and reliable Kitron and industrial partner for Kongsberg,” says Heine Østby, Managing Director, Kitron Norway. “The long-standing collaboration between our two companies continues to strengthen, and Kitron’s ongoing investment in a new production facility in Arendal is well aligned with this increase in orders. This ensures secure and efficient deliveries for this critically important...
Borregaard ASA: Invitation to Q4 2024 announcement
Written by Customer Service on . Posted in Public Companies.
22 January 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG)
Presentation of Q4 2024 results
Borregaard will report fourth quarter 2024 results on Wednesday 29 January 2025 at 07:00 CET. A stock exchange announcement will be made. A press release, the quarterly report and a presentation will be made available on https://www.borregaard.com/investors/.
A presentation of the fourth quarter 2024 results will also be held at 08:30 CET at Carnegie Investment Bank Norway, Fjordalléen 16, Oslo. We welcome you to attend physically – if so, please register by e-mail to ca@carnegie.no. The presentation can be followed live on web-TV at https://www.borregaard.com/investors/. It will be possible to ask questions via the web.
All presentations will be held in English.
For more information about Borregaard ASA, please visit https://www.borregaard.com/.
Contact:Lotte...
Belships ASA: Update on pre-acceptances
Written by Customer Service on . Posted in Public Companies.
Oslo, 22 January 2025
Reference is made to the stock exchange announcement made by Belships ASA (“Belships” or the “Company“) on 21 January 2025, regarding the approval of the offer document (the “Offer Document“) by Blue Northern BLK Ltd. (“Blue Northern” or the “Offeror“) for the recommended voluntary cash tender offer (the “Offer“) to acquire all issued and outstanding shares of Belships (the “Shares“) against a cash consideration of NOK 20.50 (the “Offer Price“) per Share, and commencement of the offer period today, 22 January 2025.
Reference is further made to the stock exchange announcement made by the Company on 19 December 2024, pursuant to which it was disclosed that the members of the Company’s board of directors (the “Board“)...
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
Written by Customer Service on . Posted in Public Companies.
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old, most of which are asymptomatic.1
FDA CLIA-waived tests broaden access to accurate, easy-to-use diagnostics for all patients in decentralized settings like urgent care centers, retail clinics, and community health venues.
The tests use highly sensitive, gold-standard PCR technology, providing results in 20 minutes to allow healthcare providers to confidently diagnose and determine appropriate treatment in the same visit.Basel, 22 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas® liat sexually transmitted infection (STI) multiplex...
Patrik Hammarén appointed as President of Nokia Technologies
Written by Customer Service on . Posted in Public Companies.
Nokia Corporation Stock Exchange Release22 January 2025 at 08:00 EET
Patrik Hammarén appointed as President of Nokia TechnologiesPatrik Hammarén appointed as President of Nokia Technologies and member of the Nokia Group Leadership TeamEspoo, Finland – Nokia today announced the appointment of Patrik Hammarén as President of Nokia Technologies and member of the Nokia Group Leadership Team, effective 22 January 2025.
Nokia Technologies is responsible for managing and monetizing Nokia’s intellectual property, including the company’s industry leading patent portfolio. The business group licenses Nokia’s innovation and contributions to global technology standards to other companies.
Hammarén joined Nokia in 2007 and has been acting President of Nokia Technologies since October 2024. Prior to this role, Patrik held several senior positions...
Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma
Written by Customer Service on . Posted in Public Companies.
Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myelomaApproval is based on positive results from the IMROZ phase 3 study, demonstrating Sarclisa in combination with standard-of-care treatment significantly improved PFS, compared to the standard of care alone in TI NDMM
Represents third indication in the EU, including two for the treatment of adult patients with R/R MM, and one in NDMMParis, January 22, 2025. Following the adoption of a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), the EU has approved Sarclisa in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment of adult patients with newly diagnosed...
Nasdaq Report Identifies Between $25 Billion and $50 Billion in Potential Efficiency Gains in Banks’ Risk and Compliance Functions
Written by Customer Service on . Posted in Public Companies.
The savings, which would come at greater or equal effectiveness, could generate up to $1 trillion in additional lending capacity
DAVOS, Switzerland, Jan. 22, 2025 (GLOBE NEWSWIRE) — Between $25 billion and $50 billion in potential efficiency gains can be realized through targeted enhancements in banks’ Risk and Compliance functions alone without compromising effectiveness, according to a report released by Nasdaq and Boston Consulting Group (BCG). The report, titled “The New Growth Imperative: Cutting through Complexity in the Financial System” reviews the interconnected challenge of complexity and complicatedness and finds that while external complexity continues to increase, excess layers of internal complicatedness have accumulated.
“Financial institutions are particularly exposed to the exponential growth in complexity...
Sandfire America Announces New Board Member
Written by Customer Service on . Posted in Public Companies.
WHITE SULPHUR SPRINGS, Mont., Jan. 21, 2025 (GLOBE NEWSWIRE) — Sandfire Resources America Inc. (“Sandfire America” or the “Company“) announces that Gemma Tually has been appointed to the Sandfire America Board of Directors effective immediately. This occurs in conjunction with Victoria Twiss stepping down from her seat on the Board.
Ms. Tually is the Chief Legal & Compliance Officer for Sandfire Resources Ltd. (Australia); 86.9% owner of Sandfire America’s outstanding shares. Ms. Tually is a qualified solicitor with more than 20 years of legal experience working across areas including mining, dispute resolution, international trade and transport, finance, and corporate law.
The Company welcomes Ms. Tually to the SFR Board and extends its sincere thanks to Ms. Twiss for her contributions to the Board...
EHang Launches UAM Exhibition (Experience) Center in Shenzhen’s Luohu District, Showcasing First Automated Smart eVTOL Vertiport for EH216-S
Written by Customer Service on . Posted in Public Companies.
GUANGZHOU, China, Jan. 21, 2025 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Urban Air Mobility (“UAM”) technology platform company, announced the launch of its Exhibition (Experience) Center in Shenzhen’s Luohu Sports and Leisure Park. It is the world’s first EH216-S takeoff and landing site featuring a fully automated vertical lift vertiport. It also marks a new smart infrastructure in Shenzhen dedicated to the commercial operations of the EH216-S pilotless passenger-carrying aerial vehicle, establishing a groundbreaking model for electric vertical takeoff and landing (“eVTOL”) aircraft operations in urban areas.(Image: The Luohu UAM Exhibition (Experience) Center)
The Luohu UAM Center, designed by EHang, boasts an automated three-dimensional vertical lift vertiport....